Yahoo Web Search

Search results

1. • 

     Immunotherapy drug may help 'cure' advanced colorectal cancer without surgery

     MedicalNewsToday via AOL· 6 hours ago

     Giving the immunotherapy drug pembrolizumab before surgery instead of chemotherapy may help improve...

2. • Small Business - Cordele Dispatch | Cordele Dispatch

     Cordele Dispatch· 5 days ago

     The results showed a 12-month overall survival (“...

3. • 

     New combination therapy shows promise for bladder cancer patients unresponsive to standard treatment

     Medical Xpress· 4 hours ago

     The trial included patients with BCG-unresponsive carcinoma in situ of the bladder, a condition that...

4. • 

     CG Oncology reports promising bladder cancer trial results By Investing.com

     Investing.com· 3 hours ago

     The study, focusing on patients with BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC),...

5. • 

     Drug already available on NHS could help cure deadly form of bowel cancer

     Daily Telegraph· 4 days ago

     Pembrolizumab works by blocking the action of a molecule called PD-1 that hides the cancer from the...

6. • TiumBio Presents Phase 1b Interim Results for TU2218 in Combination with Pembrolizumab at ASCO 2024...

     Clearfield Progress· 5 days ago

     (Kosdaq: 321550), a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapeutics for patients with rare and incurable diseases, announced interim results ...

7. • 

     An mRNA Melanoma Vaccine Shows Promise

     Time via AOL· 6 days ago

     In the study, Moderna and Merck combined their cancer treatments—Moderna’s experimental cancer vaccine and Merck’s approved checkpoint inhibitor ...

8. • Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors...

     The Woonsocket Call· 5 days ago

     Olomorasib is an investigational, oral, potent, and highly selective second-generation inhibitor of the KRAS G12C protein.

9. • 

     Breakthrough bowel cancer drug 'could triple survival chances' for patients

     Daily Express· 4 days ago

     A blockbuster drug could triple survival chances for some bowel cancer patients by “melting away”...

10. • Small Business - Shelby County Reporter | Shelby County Reporter

      The Shelby County Reporter· 5 days ago

      Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”) (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered ...